NEW DELHI – India is considering making its voluntary Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) mandatory to curb unfair marketing practices by pharma companies, including providing incentives for doctors to prescribe their products.
NEW DELHI – India's drug regulator has made it mandatory for employees of drug manufacturing companies to be certified by a government body over the next 15 months.
NEW DELHI – India's drug regulator has made it mandatory for employees of drug manufacturing companies to be certified by a government body over the next 15 months.
NEW DELHI – Indian drug manufacturing plants were under the scanner again in August, with the U.S. FDA issuing warning letters to Pfizer Inc. and Frontida Biopharm Inc. for regulatory lapses observed during inspections in plants operating in India.
NEW DELHI – Indian drug manufacturing plants were under the scanner again in August, with the U.S. FDA issuing warning letters to Pfizer Inc. and Frontida Biopharm Inc. for regulatory lapses observed during inspections in plants operating in India.
NEW DELHI – India’s drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has fixed price caps on 24 essential drugs used for the treatment of cancer, HIV, bacterial infections, anxiety and cardiac conditions, a move that is expected to cut the government’s costs by a quarter.
NEW DELHI – India’s drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has fixed price caps on 24 essential drugs used for the treatment of cancer, HIV, bacterial infections, anxiety and cardiac conditions, a move that is expected to cut the government’s costs by a quarter.
